Literature DB >> 33560395

Molecular coevolution of coagulation factor VIII and von Willebrand factor.

Philip M Zakas1, Christopher W Coyle2, Anja Brehm3, Marion Bayer3, Barbara Solecka-Witulska3, Caelan E Radford4, Christine Brown1, Kate Nesbitt1, Courtney Dwyer1, Christoph Kannicht3, H Trent Spencer2,5, Eric A Gaucher4, Christopher B Doering2,5, David Lillicrap1.   

Abstract

Ancestral sequence reconstruction provides a unique platform for investigating the molecular evolution of single gene products and recently has shown success in engineering advanced biological therapeutics. To date, the coevolution of proteins within complexes and protein-protein interactions is mostly investigated in silico via proteomics and/or within single-celled systems. Herein, ancestral sequence reconstruction is used to investigate the molecular evolution of 2 proteins linked not only by stabilizing association in circulation but also by their independent roles within the primary and secondary hemostatic systems of mammals. Using sequence analysis and biochemical characterization of recombinant ancestral von Willebrand factor (VWF) and coagulation factor VIII (FVIII), we investigated the evolution of the essential macromolecular FVIII/VWF complex. Our data support the hypothesis that these coagulation proteins coevolved throughout mammalian diversification, maintaining strong binding affinities while modulating independent and distinct hemostatic activities in diverse lineages.
© 2021 by The American Society of Hematology.

Entities:  

Year:  2021        PMID: 33560395      PMCID: PMC7876868          DOI: 10.1182/bloodadvances.2020002971

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  58 in total

1.  High level expression of recombinant porcine coagulation factor VIII.

Authors:  Christopher B Doering; John F Healey; Ernest T Parker; Rachel T Barrow; Pete Lollar
Journal:  J Biol Chem       Date:  2002-07-23       Impact factor: 5.157

2.  Hyperstability and substrate promiscuity in laboratory resurrections of Precambrian β-lactamases.

Authors:  Valeria A Risso; Jose A Gavira; Diego F Mejia-Carmona; Eric A Gaucher; Jose M Sanchez-Ruiz
Journal:  J Am Chem Soc       Date:  2013-02-14       Impact factor: 15.419

3.  Plasma levels of platelet aggregating factor/vom Willebrand factor in various species.

Authors:  K M Brinkhous; B D Thomas; S A Ibrahim; M S Read
Journal:  Thromb Res       Date:  1977-09       Impact factor: 3.944

4.  A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.

Authors:  W Deng; Y Wang; S A Druzak; J F Healey; A K Syed; P Lollar; R Li
Journal:  J Thromb Haemost       Date:  2017-08-09       Impact factor: 5.824

5.  Enhanced biosynthesis of coagulation factor VIII through diminished engagement of the unfolded protein response.

Authors:  Harrison C Brown; Bagirath Gangadharan; Christopher B Doering
Journal:  J Biol Chem       Date:  2011-05-23       Impact factor: 5.157

Review 6.  Preclinical testing of human recombinant von Willebrand factor: ADAMTS13 cleavage capacity in animals as criterion for species suitability.

Authors:  Eva-Maria Muchitsch; Barbara Dietrich; Hanspeter Rottensteiner; Wilfried Auer; Dirk Nehrbass; Herbert Gritsch; Hartmut J Ehrlich; Peter L Turecek; Hans Peter Schwarz
Journal:  Semin Thromb Hemost       Date:  2010-07-14       Impact factor: 4.180

7.  Phylogenetic and functional analysis of ADAMTS13 identifies highly conserved domains essential for allosteric regulation.

Authors:  Joshua Muia; Jian Zhu; Suellen C Greco; Karen Vanhoorelbeke; Garima Gupta; Lisa A Westfield; J Evan Sadler
Journal:  Blood       Date:  2019-01-30       Impact factor: 22.113

8.  ADAMTS13 cleavage efficiency is altered by mutagenic and, to a lesser extent, polymorphic sequence changes in the A1 and A2 domains of von Willebrand factor.

Authors:  Cynthia M Pruss; Colleen R P Notley; Carol A Hegadorn; Lee A O'Brien; David Lillicrap
Journal:  Br J Haematol       Date:  2008-11       Impact factor: 6.998

9.  Characterisation of mutations and molecular studies of type 2 von Willebrand disease.

Authors:  Firdos Ahmad; Rifat Jan; Meganathan Kannan; Tobias Obser; Md Imtaiyaz Hassan; Florian Oyen; Ulrich Budde; Renu Saxena; Reinhard Schneppenheim
Journal:  Thromb Haemost       Date:  2012-11-22       Impact factor: 5.249

10.  Characterization of zebrafish von Willebrand factor reveals conservation of domain structure, multimerization, and intracellular storage.

Authors:  Arunima Ghosh; Andy Vo; Beverly K Twiss; Colin A Kretz; Mary A Jozwiak; Robert R Montgomery; Jordan A Shavit
Journal:  Adv Hematol       Date:  2012-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.